Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Nov 04, 4:41 PMPennant Group Q3 2026 revenue up 32% YoY to $302.3M as adjusted EPS $0.35 misses but sales beat estimates
Index
RUT
Market Cap
1.28B
Enterprise Value
1.79B
Income
35.88M
Sales
1.17B
Book/sh
10.71
Cash/sh
0.53
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
9700
IPO
Oct 01, 2019
P/E
36.68
Forward P/E
23.16
PEG
1.44
P/S
1.09
P/B
3.42
P/C
69.63
P/FCF
68.48
EV/EBITDA
21.09
EV/Sales
1.53
Quick Ratio
1.18
Current Ratio
1.18
Debt/Eq
1.30
LT Debt/Eq
1.20
Option/Short
Yes / Yes
EPS (ttm)
1.00
EPS next Y
1.58
EPS next Q
0.36
EPS this Y
18.77%
EPS next Y
12.95%
EPS next 5Y
16.07%
EPS past 3/5Y
56.07% 9.97%
Sales past 3/5Y
26.05% 19.37%
EPS Y/Y TTM
15.84%
Sales Y/Y TTM
38.67%
EPS Q/Q
53.65%
Sales Q/Q
31.96%
Insider Own
5.06%
Insider Trans
-1.00%
Inst Own
92.59%
Inst Trans
-1.02%
ROA
3.99%
ROE
10.28%
ROIC
4.34%
Gross Margin
13.03%
Oper. Margin
6.24%
Profit Margin
3.05%
SMA20
-11.19%
SMA50
-8.63%
SMA200
2.81%
Trades
Shs Outstand
34.93M
Shs Float
33.16M
52W High
44.24 -17.13%
52W Low
22.25 64.73%
Volatility
4.06% 3.21%
ATR (14)
1.93
RSI (14)
37.76
Beta
1.30
Rel Volume
3.62
Avg Volume
322.55K
Volume
663,931
Perf Week
-13.70%
Perf Month
-7.47%
Perf Quarter
-6.00%
Perf Half Y
2.60%
Perf YTD
30.23%
Perf Year
45.65%
Perf 3Y
213.87%
Perf 5Y
54.03%
Perf 10Y
-
Prev Close
44.04
Price
36.66
Change %
-16.76%
Consensus
Strong Buy
Avg. Price Target
$47.33
Implied Upside
+29.1%
Analysts9incl. previous ratings
Rating Distribution8 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 08, 2025Initiated
WWilliam Blair
Outperform
Dec 02, 2025Upgrade
TFC logoTTruist
Hold → Buy$34-7.3%
Nov 18, 2025Upgrade
WFC logoWWells Fargo
Equal Weight → Overweight$31-15.4%
Oct 24, 2025Initiated
JEF logoJJefferies
Buy$30-18.2%
Dec 19, 2024Initiated
WFC logoWWells Fargo
Equal Weight$33-10.0%
Jan 05, 2024Upgrade
SStephens
Equal-Weight → Overweight$14 → $18-50.9%
Feb 27, 2023Upgrade
SF logoSStifel
Hold → Buy$15 → $16-56.4%
Aug 25, 2022Initiated
OPY logoOOppenheimer
Outperform$22-40.0%
Jun 21, 2022Downgrade
SStephens
Overweight → Equal-Weight$23 → $17-53.6%
Mar 01, 2022Downgrade
SF logoSStifel
Buy → Hold$32 → $18-50.9%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gochnour John JChief Operating OfficerOct 23 '26Option Exercise6.105,94836,283151,412Oct 27 06:16 PM
Cheney Kirk SterlingEVP, GC and Corp SecyAug 06 '26Sale38.521,39353,66118,401Aug 10 03:49 PM
Guerisoli BrentChief Executive OfficerAug 06 '26Sale38.524,285165,06799,544Aug 10 03:49 PM
Steik Jason PaulChief Clinical OfficerAug 06 '26Sale38.521,39453,70015,106Aug 10 03:48 PM
Cheney Kirk SterlingOfficerAug 06 '26Proposed Sale38.521,39353,662Aug 06 03:39 PM
Guerisoli BrentOfficerAug 06 '26Proposed Sale38.524,285165,069Aug 06 03:28 PM
Steik Jason PaulOfficerAug 06 '26Proposed Sale38.521,39453,700Aug 06 03:25 PM
Guerisoli BrentChief Executive OfficerJul 10 '26Option Exercise4.546,24828,366106,988Jul 14 12:16 PM
Guerisoli BrentChief Executive OfficerJul 10 '26Sale41.563,159131,304103,829Jul 14 12:16 PM
Guerisoli BrentOfficerJul 10 '26Proposed Sale41.573,159131,304Jul 10 10:14 AM
Guerisoli BrentChief Executive OfficerJul 07 '26Option Exercise4.546,24928,370103,905Jul 09 11:32 AM
Guerisoli BrentChief Executive OfficerJul 07 '26Sale40.513,165128,214100,740Jul 09 11:32 AM
Guerisoli BrentOfficerJul 07 '26Proposed Sale40.513,165128,214Jul 07 11:41 AM
Guerisoli BrentChief Executive OfficerMay 22 '26Option Exercise3.848,92634,27699,910May 27 03:41 PM
Guerisoli BrentChief Executive OfficerMay 22 '26Sale35.084,508158,14095,447May 27 03:41 PM
Guerisoli BrentOfficerMay 22 '26Proposed Sale35.084,508158,140May 22 11:30 AM
Gochnour John JOfficerMay 14 '26Proposed Sale36.794,639170,675May 14 04:25 PM
Cheney Kirk SterlingEVP, GC and Corp SecyNov 11 '25Option Exercise15.093,80057,34216,920Nov 13 06:37 PM
The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the Home Health and Hospice Services, and Senior Living Services segments. The Home Health and Hospice Services segment provides a combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.
CEO & ChairmanMr. Brent J. Guerisoli
President & COOMr. John J. Gochnour
Chief Financial OfficerMs. Lynette B. Walbom CPA
Executive VPMr. Kirk S. Cheney J.D.
Chief Clinical OfficerMr. Jason P. Steik